Skip to content
Stop using now Drug recall · FDA · Published October 16, 2014

Hospira Recalls Lidocaine Injections Due to Hair Contamination

Hospira recalls 100,100 units of 1% Lidocaine HCl Injection vials due to human hair found in the stopper. Check your lot numbers and NDC.

🇺🇸 FDA recall #D-0391-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 100,100 units of 1% LIDOCAINE HCl Injection, USP (10 mg/mL, 30 mL) single-dose glass vials because human hair was found attached to the stopper. This contamination poses a risk if the medication is administered to patients. The recall covers product distributed nationwide with lot number 40-316-DK and expiration date of April 1, 2016. Read more at govinfonow.com/recall/45650-hospira-inc-recalls-1-lidocaine-hcl-injection-usp-10-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/45650-hospira-inc-recalls-1-lidocaine-hcl-injection-usp-10-mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-0391-2015

Cite this page

“Hospira Recalls Lidocaine Injections Due to Hair Contamination.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45650-hospira-inc-recalls-1-lidocaine-hcl-injection-usp-10-mg. Based on FDA recall #D-0391-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0391-2015%22&limit=1).

The FDA announced on 2014-10-16 that Hospira Inc. voluntarily recalled Lidocaine HCl Injection Vials due to particulate matter hazards. The recall affects 100,100 units distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: 1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial
  • NDC: 0409-4279-02
  • Lot#: 40-316-DK
  • Expiration Date: Exp 01APR2016

The hazard

A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper, according to the FDA.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration. Other recent recalls of similar products include the 2026-07-16 Fresenius Kabi Lidocaine HCl Injection Recall, the 2026-06-08 Asclemed Lidocaine HCl Injection Recall, and the 2026-04-02 Huons Co Lidocaine HCl Injection Recall.

How to tell if you have this one

Look for 1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vials manufactured by Hospira, Inc. Check for NDC 0409-4279-02 and Lot# 40-316-DK with an expiration date of 01APR2016.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not use any vials matching the recalled lot number and NDC due to contamination risk.

  2. Contact Your Supplier

    Reach out to your distributor or Hospira Inc. for instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Oct 16, 201412. FDA classified it Class I: Feb 13, 201523. Published in FDA’s Enforcement Report: Feb 25, 201534. FDA terminated the recall: Dec 29, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC for the affected product?

The National Drug Code (NDC) for the recalled vials is 0409-4279-02.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0391-2015 (October 16, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0391-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA